Overview
No overview information available.
Background
No background information available.
Indication
用于消化不良、肠胀气、小儿消化不良引起的腹泻。也可减少肠内氨的形成，而用于肝性脑病。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Lactasin Tablets | 国药准字H37024025 | 化学药品 | 片剂 | 4/13/2020 | |
| Lactasin Tablets | 国药准字H22020384 | 化学药品 | 片剂 | 4/8/2020 | |
| Lactasin Tablets | 国药准字H20055309 | 化学药品 | 片剂 | 9/24/2020 | |
| Lactasin Tablets | 国药准字H41022919 | 化学药品 | 片剂 | 6/5/2020 | |
| Lactasin Tablets | 国药准字H37024026 | 化学药品 | 片剂 | 4/13/2020 | |
| Lactasin Tablets | 国药准字H23023152 | 化学药品 | 片剂 | 7/2/2024 | |
| Lactasin Tablets | 国药准字H37021665 | 化学药品 | 片剂 | 4/22/2020 | |
| Lactasin Tablets | 国药准字H61022438 | 化学药品 | 片剂 | 5/27/2020 | |
| Lactasin Tablets | 国药准字H22020383 | 化学药品 | 片剂 | 4/8/2020 | |
| Lactasin Tablets | 国药准字H41023659 | 化学药品 | 片剂 | 9/14/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||